ArticleClinical kidney journal2014
Kidney disease in Aboriginal Australians: a perspective from the Northern Territory.
Article in Clinical kidney journal, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed, 53 citations in OpenAlex.
- Cost-Effectiveness of Clinical Decision Support to Improve CKD Outcomes Among First Nations Australians.Kidney international reports · 2025Article
- Genomic characterization of clinically significant blood group variants in Aboriginal Australians.Blood transfusion = Trasfusione del sangue · 2024Article
- Decomposing the gaps in healthy and unhealthy life expectancies between Indigenous and non-Indigenous Australians: a burden of disease and injury study.Population health metrics · 2024Article
- Projection of high temperature-related burden of kidney disease in Australia under different climate change, population and adaptation scenarios: population-based study.The Lancet regional health. Western Pacific · 2023Article
- Deletions inCell reports. Medicine · 2021Article
- Article
- Narrative Review of Hyperferritinemia, Iron Deficiency, and the Challenges of Managing Anemia in Aboriginal and Torres Strait Islander Australians With CKD.Kidney international reports · 2021Review
- Indigenous patient experiences of returning to country: a qualitative evaluation on the Country Health SA Dialysis bus.BMC health services research · 2018Article
- Kidney Diseases in Agricultural Communities: A Case Against Heat-Stress Nephropathy.Kidney international reports · 2018Review
- Kidneys and women's health: key challenges and considerations.Nature reviews. Nephrology · 2018Article
- CKD Screening and Surveillance in Australia: Past, Present, and Future.Kidney international reports · 2018Review
- Genetic and environmental risk factors for chronic kidney disease.Kidney international supplements · 2017Review
- Diabetes and its drivers: the largest epidemic in human history?Clinical diabetes and endocrinology · 2017Article
- An expanded nationwide view of chronic kidney disease in Aboriginal Australians.Nephrology (Carlton, Vic.) · 2016Review
- Clinical outcomes associated with albuminuria in central Australia: a cohort study.BMC nephrology · 2016Article
- Welcome to the new ckj: an open-access resource integrating clinical, translational and educational research into clinical practice.Clinical kidney journal · 2015Article
- Translational nephrology: what translational research is and a bird's-eye view on translational research in nephrology.Clinical kidney journal · 2015Article
- CKD hotspots around the world: where, why and what the lessons are. A CKJ review series.Clinical kidney journal · 2014Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This article outlines the increasing awareness, service development and research in renal disease in Aboriginal people in Australia's Northern Territory, among whom the rates of renal replacement therapy (RRT) are among the highest in the world. Kidney failure and RRT dominate the intellectual landscape and consume the most professional energy, but the underlying kidney disease has recently swung into view, with increasing awareness of its connection to other chronic diseases and to health profiles and trajectories more broadly. Albuminuria is the marker of the underlying kidney disease and the best treatment target, and glomerulomegaly and focal glomerulosclerosis are the defining histologic features. Risk factors in its multideterminant genesis reflect nutritional and developmental disadvantage and inflammatory/infectious milieu, while the major putative genetic determinants still elude detection. A culture shift of "chronic disease prevention" has been catalyzed in part by the human pain, logistic problems and great costs associated with RRT. Nowadays chronic disease management is the central focus of indigenous primary care, with defined protocols for integrated testing and management of chronic diseases and with government reimbursed service items and free medicines for people in remote areas. Blood pressure, cardiovascular risk and chronic kidney disease (CKD) are all mitigated by good treatment, which centres on renin-angiotensin system blockade and good metabolic control. RRT incidence rates appear to be stabilizing in remote Aboriginal people, and chronic disease deaths rates are falling. However, the profound levels of disadvantage in many remote settings remain appalling, and there is still much to be done, mostly beyond the direct reach of health services.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.